Task: Answer the multiple-choice question.
Question: Which drug exhibits a -40.358% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC(C)C(=O)Nc1ccc2c(c1)nc(CCN1CCN(c3ccccc3)CC1)n2C
b COc1ccc(-n2nnc3c(=O)n(Cc4cccc(C)c4)cnc32)cc1
c COc1ccc(NC(=O)C(C)Sc2ccccc2)cc1
Answer: a. CC(C)C(=O)Nc1ccc2c(c1)nc(CCN1CCN(c3ccccc3)CC1)n2C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C(=O)Nc1ccc2c(c1)nc(CCN1CCN(c3ccccc3)CC1)n2C
CC(C)C(=O)Nc1ccc2c(c1)nc(CCN1CCN(c3ccccc3)CC1)n2C
2-methyl-N-[1-methyl-2-[2-(4-phenylpiperazin-1-yl)ethyl]benzimidazol-5-yl]propanamide